1. Home
  2. OCUL vs PAX Comparison

OCUL vs PAX Comparison

Compare OCUL & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • PAX
  • Stock Information
  • Founded
  • OCUL 2006
  • PAX 1988
  • Country
  • OCUL United States
  • PAX Cayman Islands
  • Employees
  • OCUL N/A
  • PAX N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • PAX Investment Managers
  • Sector
  • OCUL Health Care
  • PAX Finance
  • Exchange
  • OCUL Nasdaq
  • PAX Nasdaq
  • Market Cap
  • OCUL 2.3B
  • PAX 2.3B
  • IPO Year
  • OCUL 2014
  • PAX 2021
  • Fundamental
  • Price
  • OCUL $11.26
  • PAX $14.00
  • Analyst Decision
  • OCUL Strong Buy
  • PAX Strong Buy
  • Analyst Count
  • OCUL 9
  • PAX 1
  • Target Price
  • OCUL $22.13
  • PAX $14.00
  • AVG Volume (30 Days)
  • OCUL 3.2M
  • PAX 561.0K
  • Earning Date
  • OCUL 11-13-2025
  • PAX 11-04-2025
  • Dividend Yield
  • OCUL N/A
  • PAX 6.28%
  • EPS Growth
  • OCUL N/A
  • PAX N/A
  • EPS
  • OCUL N/A
  • PAX 0.53
  • Revenue
  • OCUL $56,664,000.00
  • PAX $397,386,000.00
  • Revenue This Year
  • OCUL N/A
  • PAX N/A
  • Revenue Next Year
  • OCUL $18.87
  • PAX $19.89
  • P/E Ratio
  • OCUL N/A
  • PAX $26.08
  • Revenue Growth
  • OCUL N/A
  • PAX 26.48
  • 52 Week Low
  • OCUL $5.79
  • PAX $9.43
  • 52 Week High
  • OCUL $13.85
  • PAX $15.54
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 41.98
  • PAX 42.14
  • Support Level
  • OCUL $10.85
  • PAX $14.07
  • Resistance Level
  • OCUL $11.77
  • PAX $14.41
  • Average True Range (ATR)
  • OCUL 0.72
  • PAX 0.36
  • MACD
  • OCUL -0.16
  • PAX -0.13
  • Stochastic Oscillator
  • OCUL 28.63
  • PAX 5.92

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

Share on Social Networks: